Density and Benign Disease Increase Breast Cancer Risk

Women with benign breast disease and dense breast tissue have an increased risk of future breast cancer and could benefit from a tailored mammogram screening strategy. A new study published in Radiology investigated the risk of breast cancer associated with the combination of mammographic density and benign breast disease in 3.9 million Korean women. Breast cancer screening with mammography is provided for all women in Korea age 40 years or older, providing the researchers with a vast database for analysis.

Research has shown that mammographic breast density and benign breast disease are strong risk factors for breast cancer. Less is known about the combined impact of the two risk factors.

During an average follow-up of more than 10 years, more than 58,000 women developed breast cancer. Of the women who developed breast cancer, 10,729, or 18.4%, had benign breast disease.

“While these benign breast diseases are not cancerous or life-threatening, our results, together with evidence from previous findings, show that they might increase the risk of breast cancer,” said study senior author Boyoung Park, MD, PhD, from the Department of Preventive Medicine at Hanyang University College of Medicine in Seoul, Korea.

Breast cancer risk was 3.2% in women with extremely dense breasts. This was significantly higher than the 1.36% risk in women with fatty breast tissue.

Together, the two risk factors raised the risk of breast cancer when compared with women with non-dense breasts and those without benign breast disease.

The study was the largest to examine benign breast disease and breast density in East Asian women. Its findings suggest that women with dense breast tissue and a history of benign breast disease may benefit from a tailored screening regimen. Supplemental screening with MRI or ultrasound is often recommended for women at high risk of breast cancer.

“With the current findings, we believe that women with dense breasts and the presence of benign breast disease would be potential targets for supplemental screening,” said coauthor Soyeoun Kim, MPH, a PhD candidate in Dr Park’s lab.

Screening frequency may also need to be adjusted in these women. Current recommendations vary from country to country. The American Cancer Society (ACS), for instance, recommends yearly screening in women beginning at age 45, with the option to begin at age 40. High-risk women should get yearly mammography and breast MRI starting at age 30, according to ACS recommendations.

The researchers are currently working on a larger project with the ultimate goal of developing a new breast cancer prediction model.

“We plan to develop a breast cancer prediction model that is more relevant to Asian women and includes new features that were not considered in the previous prediction models, such as benign breast diseases and breast density detected on mammograms,” Dr Park said.